Steven Pieper

Filings by Steven Pieper span 2 companies, the busiest being Xeris Biopharma Holdings, Inc. and Xeris Pharmaceuticals Inc. Over a trading history stretching from 28 July 2021 to 1 October 2026, the count stands at 18 filings.

Both buying and selling appear: 2 purchases worth €93k, against 4 sales worth €413k. The net balance comes to €320k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 9 share grants and 2 option exercises. So far in 2026, the count stands at no purchases and 4 sales.

Most recently, on 2 October 2026, the filings show an open-market sale worth €41k in Xeris Biopharma Holdings, Inc. The clock since the last published purchase (21 November 2023) now reads 1,062 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.